Mezigdomide plus Dexamethasone in Relapsed and Refractory Multiple Myeloma

ByThe Short Paper

This study tested a new treatment called mezigdomide, combined with dexamethasone, for people with multiple myeloma (a type of cancer). The treatment showed promise in patients who had already tried other treatments, including those resistant to lenalidomide and pomalidomide. In the first phase of the study, they tested the treatment on 77 patients to determine…

Ferric Carboxymaltose in Heart Failure with Iron Deficiency

ByThe Short Paper

This study looked at a treatment called ferric carboxymaltose for people with heart failure who also had low iron levels. They compared it to a placebo (a fake treatment) alongside standard heart failure therapy. The study involved over 3,000 patients. The results showed that there wasn’t a significant difference between the two groups in terms…